Stability of cisatracurium besylate in vials, syringes, and infusion admixtures

American Journal of Health-System Pharmacy

Volumn 55, Issue 10, 1998, Pages 1037-1041

  Xu, Quanyun A ^a   Zhang, Yan Ping ^a   Trissel, Lawrence A ^a,d   Gilbert, Doward L ^b   Martinez, J Frank ^b   Fox, Janet L ^c  

^a Clinical Pharmaceutics ^*

^b UNIVERSITY OF TEXAS   (United States)

^c GLAXOSMITHKLINE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Additives; Cisatracurium besylate; Concentration; Containers; Dextrose; Diluents; Incompatibilities; Injecti ons; Photodecomposition; Polyvinyl chloride; Skeletal muscle relaxants; Sodium chloride; Stability; Storage; Syringes; Temperature; Vials

Indexed keywords

CISATRACURIUM; DILUENT; DRUG ADDITIVE; MUSCLE RELAXANT AGENT;

ARTICLE; DRUG DECOMPOSITION; DRUG PACKAGING; DRUG STABILITY; ENVIRONMENTAL TEMPERATURE; PHOTODEGRADATION; PRIORITY JOURNAL;

EID: 0032524171     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/55.10.1037     Document Type: Article

References (4)

1. Nimbex package insert. Research Triangle Park, NC: Glaxo Wellcome; 1995 Jun.
2. Trissel LA, Martinez JF. Physical compatibility of melphalan with selected drugs during simulated Y-site administration. Am J Hosp Pharm. 1993; 50:2359-63.
3. Trissel LA, Bready BB. Turbidimetric assessment of the compatibility of taxol with selected other drugs during simulated Y-site injection. Am J Hosp Pharm. 1992; 49:1716-9.
4. Nimbex test instructions. Research Triangle Park, NC: Burroughs-Wellcome; 1996 Jan 30.